02.21.23
Norwood, MA-based life science company Entrinsic Bioscience, LLC (EBS) has expanded its lineup of medical foods with the launch of enterade IBS-D, which is developed for dietary management of GI symptoms associated with Irritable Bowel Syndrome with Diarrhea (IBS-D), including diarrhea, dehydration, bowel urgency, and abdominal discomfort.
The unique formula of amino acids and electrolytes was chosen based on their ability to naturally support and maintain digestive function while replenishing fluid loss, electrolytes, and minerals caused by frequent diarrhea. enterade IBS-D also contains chamomile and ginger.
"IBS-D affects over 16 million people in the United States alone,” said Stephen Gatto, CEO of Entrinsic Bioscience. “It is among the most burdensome chronic conditions reported by patients and we're proud to be able to provide support to those living with the diarrhea, dehydration, and other symptoms associated with IBS-D."
enterade IBS-D joins the flagship product, enterade Advanced Oncology Formula, a plant-based medical food that has been shown to reduce the GI side effects of cancer treatments. enterade Advanced Oncology Formula is a breakthrough product in supportive care for GI side effects, including nausea, diarrhea, dehydration, weight loss, and fatigue. It has been used by patients at over 500 cancer treatment centers nationwide, according to the company.
"The science of enterade originated from a NASA grant to develop solutions for severe GI distress caused by deep space travel," noted Dr. Robert Kenefick, senior vice president of research and development. "Using that same technology, we've been able to address GI symptoms in patients with IBS-D."
Entrinsic Bioscience combines its proprietary platform and discovery engine to deliver patented, next generation therapeutic compositions, functional ingredients, and product innovations designed to provide multiple consumer health and wellness benefits. Through proprietary bio-mapping and electrophysiology techniques, the EBS platform harnesses the body's natural processes to restore, protect and enhance health and wellness.
The unique formula of amino acids and electrolytes was chosen based on their ability to naturally support and maintain digestive function while replenishing fluid loss, electrolytes, and minerals caused by frequent diarrhea. enterade IBS-D also contains chamomile and ginger.
"IBS-D affects over 16 million people in the United States alone,” said Stephen Gatto, CEO of Entrinsic Bioscience. “It is among the most burdensome chronic conditions reported by patients and we're proud to be able to provide support to those living with the diarrhea, dehydration, and other symptoms associated with IBS-D."
enterade IBS-D joins the flagship product, enterade Advanced Oncology Formula, a plant-based medical food that has been shown to reduce the GI side effects of cancer treatments. enterade Advanced Oncology Formula is a breakthrough product in supportive care for GI side effects, including nausea, diarrhea, dehydration, weight loss, and fatigue. It has been used by patients at over 500 cancer treatment centers nationwide, according to the company.
"The science of enterade originated from a NASA grant to develop solutions for severe GI distress caused by deep space travel," noted Dr. Robert Kenefick, senior vice president of research and development. "Using that same technology, we've been able to address GI symptoms in patients with IBS-D."
Entrinsic Bioscience combines its proprietary platform and discovery engine to deliver patented, next generation therapeutic compositions, functional ingredients, and product innovations designed to provide multiple consumer health and wellness benefits. Through proprietary bio-mapping and electrophysiology techniques, the EBS platform harnesses the body's natural processes to restore, protect and enhance health and wellness.
